FLAVA Vape Raid: OXVA & Romio may Suffer Heavy Losses as Philippines Market Sees Reshuffle

Business by 2FIRSTS, edited by Sophia
Mar.05.2024
FLAVA Vape Raid: OXVA & Romio may Suffer Heavy Losses as Philippines Market Sees Reshuffle
Philippine Customs seized unregistered, unauthorized e-cigarette products worth 4 billion pesos, impacting Chinese brands like Romio and OXVA.

On the evening of February 29th, the Philippine Bureau of Customs Intelligence and Investigation Services seized a shipment of e-cigarette products valued at 4 billion pesos (approximately 510 million RMB, 70 billion USD) that were not registered in the Philippines and lacked the necessary authorization certificates. The confiscated FLAVA vape products are believed to have originated from the Philippines. (Read more: Breaking: Philippines Authorities Seize $70 Million's Flava Products)

 

Against this backdrop, 2FIRSTS had discussions with several individuals who are familiar with the e-cigarette market in the Philippines to understand the current situation of the market.

 

FLAVA is the leading distribution brand in the Philippines. It is understood that the Philippines has three major distribution companies, namely FLAVA, DENKAT, and SHIFT. Any brand looking to enter the Philippine market through these channels needs to establish a co-branding partnership with them. For example, the e-cigarette brand OXBAR (from OXVA) sold in the Philippines market carries the FLAVA brand logo on its product packaging and promotional materials.

 

FLAVA Vape Raid: OXVA & Romio may Suffer Heavy Losses as Philippines Market Sees Reshuffle
OXBAR products sold in the Philippines market come with the FLAVA logo | Image source: OXBAR

 

According to sources, the recent seizure of goods by FLAVA has had a significant impact on the Chinese companies they were working with. FLAVA did not fully pay for the goods they were purchasing, with some orders only paying 30% to 50%, and even as low as 20%. 

 

According to sources familiar with the e-cigarette market in the Philippines, Romio (from Shenzhen Maoanda Technology Co., Ltd. according to QCC) and OXVA (from Shenzhen Future Tech CO., Limited according to QCC), which have the closest cooperation with FLAVA, are considered the two Chinese brands most affected by this event. Among the products released on FLAVA's official social media platforms, Romio and OXBAR, a brand under OXVA, are the two brands with the highest frequency of appearance.

 

FLAVA Vape Raid: OXVA & Romio may Suffer Heavy Losses as Philippines Market Sees Reshuffle
Romio products in collaboration with FLAVA | Image source: Filipino distribution website

 

Judging from FLAVA's social media account, the brands that are also associated with them include GEEK BAR, FLONQ, and NIMMBOX.

 

FLAVA Vape Raid: OXVA & Romio may Suffer Heavy Losses as Philippines Market Sees Reshuffle
Image source: FLAVA social media account

 

Sources revealed that the e-cigarette market in the Philippines is currently in a state of extreme chaos. Some brands planning to enter the market are feeling uneasy, as they are facing difficulties in collecting payments from distributors, who are refusing their requests. 

 

Furthermore, with FLAVA experiencing heavy losses, the e-cigarette market in the Philippines is currently undergoing a period of restructuring. Distributor SHIFT is seizing this opportunity to aggressively expand its channel business and has launched a promotion offering a free motorcycle with the purchase of an e-cigarette. As a result, many industry insiders speculate that after FLAVA's decline, SHIFT could become the "new king." According to insiders, SHIFT was founded by Filipino real estate and casino businessmen, with strong backing.

 

2FIRSTS will continue to monitor the dynamics of the e-cigarette market in the Philippines and will provide updates on the 2FIRSTS mobile app and www.2firsts.com in a timely manner. Stay tuned for more information.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Australia’s TGA Places Nicotine Pouches Under Therapeutic Goods Rules From July 24, Blocking Imports of Unapproved Products
Australia’s TGA Places Nicotine Pouches Under Therapeutic Goods Rules From July 24, Blocking Imports of Unapproved Products
Australia is strengthening controls on nicotine pouches under its existing therapeutic goods regulatory framework. According to the Therapeutic Goods Administration (TGA), nicotine pouch products must meet regulatory requirements, and unapproved products cannot be legally imported. The move follows Australia’s broader approach of maintaining strict oversight of nicotine products, including nicotine-containing vapes. As nicotine pouches expand globally, Australia’s regulatory approach highlights growing differences in how countries manage emerging smoke-free nicotine products.
Regulations
Jul.27
Philippines Customs Seizes PHP11.68 Billion($200 Million) in Illegal Tobacco and Vapes in First Seven Months of 2026
Philippines Customs Seizes PHP11.68 Billion($200 Million) in Illegal Tobacco and Vapes in First Seven Months of 2026
Philippines Customs data showed that illegal cigarettes and vape products seized during the first seven months of 2026 were valued at about PHP11.68 billion, exceeding the PHP2.516 billion recorded for the full year of 2025. The figures were disclosed by a Bureau of Customs official during a House Committee on Ways and Means hearing on tobacco excise tax reforms. Vape-related seizures were valued at about PHP1.65 billion, with most cases recorded at the Manila International Container Port. Customs officials said enforcement against illicit tobacco trade would continue.
Aug.26
China Discloses First Criminal Case Over Counterfeit Vapes Disguised as “Medical Nebulizers” and “Zero-Nicotine” Products
China Discloses First Criminal Case Over Counterfeit Vapes Disguised as “Medical Nebulizers” and “Zero-Nicotine” Products
Chinese authorities have disclosed the country’s first reported criminal case involving counterfeit vapes marketed as “medical nebulizers” and “zero-nicotine” products. Authorities determined that the products involved were counterfeit vapes and pursued criminal charges for producing and selling counterfeit goods. According to the report, the case resulted in the seizure of 347,000 counterfeit vape pods and 53,700 vape devices, with physical goods valued at 22.13 million yuan.
Aug.04
JTI Makes Third Bet on South Korea as Ploom AURA Enters a Market Dominated by lil and IQOS
JTI Makes Third Bet on South Korea as Ploom AURA Enters a Market Dominated by lil and IQOS
Japan Tobacco International is stepping up its heated tobacco push in South Korea with Ploom AURA. Since its official launch in April 2026, the device's limited First Edition and Glacier White version have sold out, while distribution has expanded across Seoul, Incheon, Gyeonggi Province and airport duty-free channels. The rollout marks JTI's third major attempt to build a stronger heated tobacco position in South Korea, following Ploom TECH in 2019 and Ploom X Advanced in 2024. At the group level, JT plans to invest about ¥800 billion, approximately $5 billion, in reduced-risk products from 2026 through 2028, with heated products and Ploom identified as its primary investment priority.
Aug.14
JTI’s Nordic Spirit Signs Co-op Live Partnership Ahead of New UK Nicotine Sponsorship Restrictions
JTI’s Nordic Spirit Signs Co-op Live Partnership Ahead of New UK Nicotine Sponsorship Restrictions
JTI nicotine pouch brand Nordic Spirit has entered a long-term partnership with Manchester’s Co-op Live, becoming the venue’s Official Nicotine Pouch Partner. The 23,500-capacity venue is the UK’s largest indoor live entertainment arena. Nordic Spirit will run in-venue activations for existing adult nicotine consumers and sell products at selected arena bars. The agreement was entered into before the relevant UK sponsorship restrictions were introduced, while the government intends to implement a comprehensive ban on advertising and sponsorship of vaping and nicotine products from June 1, 2027.
Sep.07
U.S. Ninth Circuit Upholds FDA Denial of MH Global’s Flavored Vape PMTA Applications
U.S. Ninth Circuit Upholds FDA Denial of MH Global’s Flavored Vape PMTA Applications
The U.S. Court of Appeals for the Ninth Circuit upheld the FDA’s denial of MH Global LLC’s applications to market flavored electronic nicotine delivery systems (ENDS). The court ruled that FDA’s comparative-efficacy framework, which requires applicants to show that flavored products provide greater cessation or switching benefits than tobacco-flavored alternatives, is consistent with the Tobacco Control Act’s “appropriate for the protection of the public health” standard. The court also found that FDA was not required to establish the framework through notice-and-comment rulemaking.
Aug.26